(Q34622324)

3 August 2017

1 reference

title

Sympatholytic therapy in primary hypertension: a user friendly role for the future (English)

1 reference

3 August 2017

DeQuattro V

1

1 reference

3 August 2017

Li D

series ordinal

2

1 reference

3 August 2017

publication date

1 March 2002

1 reference

Journal of Human Hypertension

3 August 2017

published in

1 reference

3 August 2017

volume

16 Suppl 1

1 reference

3 August 2017

page(s)

S118-23

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001356

3 August 2017

exact match

0 references

cites work

Control of hypertension by hexamethonium and 1-hydrazinophthalazine; preliminary observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Catecholamine turnover in normotensive and hypertensive man: effects of antiadrenergic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Effects of clonidine on central and peripheral nerve tone in primary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Pathophysiologic and pharmacokinetic determinants of the antihypertensive response to propranolol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Neural mechanisms in primary hypertension. Efficacy of alpha-blockade with doxazosin during stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Chronic I(1)-imidazoline agonism : sympathetic mechanisms in hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Increased blood pressure and neural tone in the silent ischemia of hypertension: disparate effects of immediate release nifedipine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Equivalent reduction of proteinuria in hypertensives by either nifedipine GITS or enalapril: disparate effects on neurohormones and ambulatory blood pressure and the influence of salt

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Effects of losartan and captopril on QT dispersion in elderly patients with heart failure. ELITE study group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001356

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001356

1 reference

Dimensions Publication ID

3 August 2017

1001450808

0 references

1 reference